BMS’ Cell Therapy For Lymphoma On Track For EU-Wide Approval
Breyanzi’s EU Approval Will Introduce A Third CAR-T Therapy To The LBCL Market
Several new drugs are now on track for an EU marketing authorization after getting the EMA’s thumbs up this week.
